Attached files
Exhibit 3.15
CERTIFICATE OF AMENDMENT
TO THE
CERTIFICATE OF INCORPORATION
OF
MEDITE CANCER DIAGNOSTICS, INC.
Pursuant to Section 242 of the
General Corporation Law of the State of Delaware
Medite
Cancer Diagnostics, Inc., a Delaware corporation (the
“Corporation”), does hereby certify as
follows:
1. The
Board of Directors of the Corporation (the “Board”),
acting by Unanimous Written Consent in accordance with Section
141(f) of the General Corporation Law of the State of Delaware (the
“DGCL”) adopted a resolution authorizing the
Corporation to decrease the number of shares of the common stock,
$.001 par value per share (the “Common Stock”) that the
Corporation is authorized to issue from 3,500,000,000 to 35,000,000
and to file this Certificate of Amendment:
Article
FOURTH of the Certificate of Incorporation shall be amended by
deleting Section 4.1 in its entirety and submitting therefor the
following:
“Section
4.1. The total number of shares of stock which the Corporation is
authorized to issue is Forty Five Million (45,000,000) shares,
comprised of Thirty Five Million (35,000,000) shares of common
stock, par value $0.001 per share, and Ten Million (10,000,000)
shares of preferred stock, par value $0.001 per
share.”
2. That
in lieu of a meeting and vote of stockholders, the holders of a
majority in interest of record of the issued and outstanding shares
of Common Stock have given written consent to said amendment in
accordance with the provisions of Section 228 of the
DGCL.
3. That
the aforesaid amendment was duly adopted in accordance with the
applicable provisions of Section 242 of the DGCL.
IN WITNESS WHEREOF, Medite Cancer Diagnostics, Inc. has caused this
Certificate of Amendment to be duly executed in its corporate name
this 18th day of February, 2016.
MEDITE CANCER DIAGNOSTICS, INC.
By:
/s/Michaela
Ott
Michaela
Ott, CEO
Filed
with the State of Delaware on February 19, 2016